Makers Laboratories Ltd (MAKERSL) — Announcement | 1 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
CARE Edge reaffirms Makers Laboratories' long-term bank facilities rating at BBB+ Stable
💡 Investor Takeaway
The reaffirmation indicates no downgrade risk and stable banking relationships for the company.

Makers Laboratories Ltd announced that CARE Edge Ratings reaffirmed its long-term bank facilities rating at CARE BBB+ with a Stable outlook, maintaining the existing rating without any change. This credit rating action confirms the company's current financial standing with its banking partners.

📄 View Original Announcement (PDF)

About Makers Laboratories Ltd (MAKERSL)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹110.34 Cr P/E: 32.3 ROE: 15.3% ROCE: 20.9%

View full MAKERSL stock details →

📡 Get AI alerts when MAKERSL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAKERSL — Free

📊 More MAKERSL filings

No other filings yet.

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAKERSL files new disclosures

Track MAKERSL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAKERSL — Free

Free account · 2 AI queries/day